mounjaro tirzepatide injectie afvallen Mounjaro bijwerkingen: veilig afvallen uitgelegd

Tirzepatide (Mounjaro, Zepbound) is a once-weekly subcutaneous injection approved by the FDA for type 2 diabetes management and chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity

Pernicious anaemia is caused by a deficiency in vitamin B12, due to atrophic gastritis, an autoimmune condition where the immune system destroys self, in this case the parietal cells of the stomach

Vitamin D deficiency is also linked to an increased risk of chronic diseases, and addressing this deficiency through vitamin D injections can help mitigate these risks

How to use: Take equal parts of fresh lemon juice and honey in a bowl